Structural Basis of an N-Degron Adaptor with More Stringent Specificity  by Stein, Benjamin J. et al.
ArticleStructural Basis of an N-Degron Adaptor with More
Stringent SpecificityGraphical AbstractHighlightsd A. tumefaciens ClpS1 binds and delivers N-degron Phe, Tyr,
Trp, and Leu to ClpA
d A. tumefaciens ClpS2 binds and delivers only N-degron Phe,
Tyr, and Trp to ClpA
d Apo and holo ClpS2 structures reveal distinct conformations
that define specificity
d The paralogs are at different levels, with ClpS2 increasing at
stationary phaseStein et al., 2016, Structure 24, 232–242
February 2, 2016 ª2016 Elsevier Ltd All rights reserved
http://dx.doi.org/10.1016/j.str.2015.12.008Authors
Benjamin J. Stein, Robert A. Grant,
Robert T. Sauer, Tania A. Baker
Correspondence
tabaker@mit.edu
In Brief
The ClpS adaptor is responsible for
delivering N-end-rule substrates to ClpAP
for degradation in bacteria. Stein et al.
present biochemical and structural
evidence that A. tumefaciens employs an
additional more selective ClpS protein,
ClpS2, allowing fine-tuning of N-end-rule
recognition and unfolding/degradation.Accession Numbers4YJM
4YJX
4YKA
Structure
ArticleStructural Basis of an N-Degron Adaptor
with More Stringent Specificity
Benjamin J. Stein,1 Robert A. Grant,1 Robert T. Sauer,1 and Tania A. Baker1,2,*
1Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
2Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
*Correspondence: tabaker@mit.edu
http://dx.doi.org/10.1016/j.str.2015.12.008SUMMARY
The N-end rule dictates that a protein’s N-terminal
residue determines its half-life. In bacteria, the ClpS
adaptor mediates N-end-rule degradation, by recog-
nizing proteins bearing specific N-terminal residues
and delivering them to the ClpAPAAA+ protease. Un-
like most bacterial clades, many a-proteobacteria
encode two ClpS paralogs, ClpS1 and ClpS2. Here,
we demonstrate that both ClpS1 and ClpS2 from
A. tumefaciens deliver N-end-rule substrates to
ClpA, but ClpS2 has more stringent binding speci-
ficity, recognizing only a subset of the canonical
bacterial N-end-rule residues. The basis of this
enhanced specificity is addressed by crystal struc-
tures of ClpS2, with and without ligand, and
structure-guided mutagenesis, revealing protein
conformational changes and remodeling in the sub-
strate-binding pocket. We find that ClpS1 and
ClpS2 are differentially expressed during growth in
A. tumefaciens and conclude that the use of multiple
ClpS paralogs allows fine-tuning of N-end-rule
degradation at the level of substrate recognition.
INTRODUCTION
Proteolysis is critical in all organisms for removing misfolded
and/or damaged proteins and regulating central biological pro-
cesses (Sauer and Baker, 2011). All organisms contain AAA+
proteolytic machines that use the energy of ATP hydrolysis to un-
fold substrates for degradation (Sauer and Baker, 2011; Sauer
et al., 2004). Bacterial substrates are targeted for proteolysis
by peptide sequences, called degrons, often located at the
N or C terminus of a target protein, to ensure that only specific
proteins are degraded. These degrons may be recognized
directly by a AAA+ protease or require the assistance of an
adaptor protein, such as ClpS (Sauer and Baker, 2011).
The N-end rule describes a proteolytic pathway, present in
prokaryotes and eukaryotes, in which the N-terminal amino
acid of a protein determines its half-life (Dougan et al., 2011; Var-
shavsky, 2011). This pathway has been implicated in oxygen ho-
meostasis, cell division, cardiovascular development, apoptosis,
putrescine homeostasis, and other processes (Hu et al., 2008;
Humbard et al., 2013; Lee et al., 2005; Licausi et al., 2011; Ninnis232 Structure 24, 232–242, February 2, 2016 ª2016 Elsevier Ltd All ret al., 2009; Piatkov et al., 2012; Rao et al., 2001; Schmidt et al.,
2009; Varshavsky, 2011). In bacteria such asEscherichia coli and
Caulobacter crescentus, four hydrophobic N-terminal residues
(Phe, Tyr, Trp, Leu) serve as N-end-rule degradation signals
(N-degrons). The N-degrons of bacterial substrates are bound
directly by ClpS, assembling into a ternary complex with the
ClpAP AAA+ protease (Figure 1A) (Erbse et al., 2006; Rivera-
Rivera et al., 2014; Roma´n-Herna´ndez et al., 2011; Tobias
et al., 1991). The substrate is then transferred to ClpAP by an
active-handoff mechanism involving remodeling of ClpS by
ClpA (Rivera-Rivera et al., 2014; Roma´n-Herna´ndez et al.,
2011). Interestingly, ClpS also inhibits the degradation of certain
ClpAP substrates, such as ssrA-tagged proteins (De Donatis
et al., 2010; Dougan et al., 2002; Hou et al., 2008).
Much work has been done to determine how ClpS recognizes
N-end-rule substrates. Crystallographic studies show that the
side chain of each N-end-rule residue packs into a hydrophobic
pocket in ClpS, and the N-degron a-amino group forms three
hydrogenbonds (one coordinatedbywater) withClpS (Figure 1B)
(Roma´n-Herna´ndez et al., 2009; Wang et al., 2008b). In eukary-
otes, the N-end-rule degradation pathway acts at the level of
substrate ubiquitination. Several E3 ubiquitin ligases use a pro-
tein domain, homologous to ClpS, to dock substrates with N-ter-
minal Phe, Tyr, Trp, Leu, or Ile residues, before mediating their
ubiquitination (Varshavsky, 2011). Moreover, eukaryotes employ
multiple E3 ubiquitin ligases, with differing substrate prefer-
ences, to regulate N-end-rule recognition.
ClpS is conserved throughout proteobacteria and is also
found in some more distant genera, including cyanobacteria
and actinobacteria, as well as in plant chloroplasts (Lupas and
Koretke, 2003). Interestingly, although bacterial species gener-
ally encode a single ClpS or ClpS1 protein, many a-proteobacte-
ria also encode a second, more divergent ClpS2 protein
(Figure 1C) (Lupas and Koretke, 2003). The gene encoding
ClpS or ClpS1 is almost always adjacent to the gene for ClpA,
whereas the gene encoding ClpS2 is present elsewhere in the
genome. Similar to a-proteobacteria, cyanobacteria also encode
ClpS1 and ClpS2 adaptors, although both are divergent in
sequence from the a-proteobacterial ClpS1 and ClpS2 proteins
(Figure 1C). In this study, we initially perform a high-throughput
binding analysis of the ClpS proteins from Agrobacterium tume-
faciens (an a-proteobacterium) and Synechococcus elongatus
(a cyanobacterium) and then investigate the binding specificity,
delivery capabilities, and expression of A. tumefaciens ClpS1
and ClpS2.We find thatA. tumefaciensClpS2 binds and delivers
a more restricted set of N-end-rule substrates than does ClpS1.
The structure of ClpS2, with and without bound substrate,ights reserved
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Figure 1. ClpS and N-End-Rule Recognition
(A) The ClpAP protease is composed of the barrel-
shaped ClpP peptidase (green) and AAA+ ClpA un-
foldase (dark blue). The ClpS adaptor protein (cyan)
binds both N-end-rule substrates (pink) and the ClpA
N-terminal domain, which is flexibly attached to the
body of ClpA.
(B) Structure of C. crescentus ClpS bound to N-ter-
minal Tyr (PDB: 3DNJ). The unstructured N-terminal
extension, the N-degron binding pocket, and ClpA-
interacting residues are indicated. Zoom box: The
a-amino group of Tyr is coordinated by three
hydrogen bonds involving His79, Asp49, and Asn47 of
C. crescentus ClpS and a water molecule (red
sphere).
(C) Sequence alignment of ClpS proteins from E. coli,
C. crescentus,A. tumefaciens, and S. elongatus. The
alignment is colored by conservation from lower
conservation (light blue) to higher conservation (dark
blue). Binding-pocket residues are indicated by
black stars. ClpA-interacting residues are indicated
by red stars. The alignment was constructed using
Clustal Omega (Sievers et al., 2011) and Jalview
(Waterhouse et al., 2009).suggests how this selective binding is achieved. We also find
that ClpS1 and ClpS2 are differentially expressed during growth
in A. tumefaciens. Together, our results strongly suggest that
A. tumefaciens, and most likely other a-proteobacteria and cya-
nobacteria, employs multiple ClpS proteins to tune N-end-rule
recognition and proteolysis under different growth conditions.
RESULTS
Bacterial ClpS1 and ClpS2 Proteins Differ in Binding
Specificity
To rapidly assess the N-terminal-binding specificities of ClpS1
and ClpS2 protein pairs from a-proteobacteria and cyanobacte-
ria, we synthesized carboxy-terminally coupled peptide arrays in
which the 20 common amino acids were placed at the N-terminal
(P1) and penultimate (P2) residues of the peptide P1-P2-
FVQELASKEV. We then probed these arrays with purified
35S-labeled ClpS1 or ClpS2 from A. tumefaciens and S. elonga-
tus and imaged the bound radioactive proteins. As observed
previously for E. coli ClpS (Erbse et al., 2006), A. tumefaciens
ClpS1 recognized peptides with N-terminal Phe, Tyr, Trp, or
Leu residues and did not recognize peptides with N-terminal
Ala, Val, or Ile (Figure 2A). In contrast, A. tumefaciens ClpS2
did not detectably bind peptides with N-terminal Leu and
showed reduced binding to peptides with N-terminal Tyr and
Trp (Figure 2B). ClpS1 from the bacterial species S. elongatus
did not detectably recognize peptides with N-terminal Leu but
bound peptides with N-terminal Phe, Tyr, and Trp (Figure 2C).
S. elongatus ClpS2, by contrast, bound N-end-rule Leu, Phe,
and Tyr, as well as the b-branched amino acids Val and Ile (Fig-
ure 2D). In all cases, we found that Arg or Lys at the P2 position
increased binding, whereas Asp or Glu at P2 decreased binding
(Figures 2A–2D), presumably due to ionic interactions with the
negatively charged residues in the ClpS binding pocket. More-Structure 24, 23over, all of the ClpS proteins seemed to favor small residues,
such as Gly and Ser, at the P2 position. The small side chains
of these amino acids likely avoid clashes with residues at the
rim of the ClpS binding pocket. Thus, within a species, ClpS1
and ClpS2 proteins appear to differ in their P1 binding specific-
ities. Moreover, the observed specificity differences are not
conserved between a-proteobacteria and cyanobacteria. These
results indicate that ClpS variants in different bacteria have
evolved to recognize species-specific N-degron profiles. We
chose to characterize the A. tumefaciens ClpS1 and ClpS2 pro-
teins, which were more biochemically tractable, in greater detail.
The ClpS2 Adaptor Is More Selective than ClpS1 in
A. tumefaciens
To quantitatively assess A. tumefaciens ClpS binding specific-
ities, we used fluorescence anisotropy to assay the binding of
ClpS1 and ClpS2 to P1-RFVQELASKEVC-fluorescein peptides
with Phe (Fpep), Tyr (Ypep), Trp (Wpep), and Leu (Lpep) at the
N-terminal P1 position. ClpS1 bound these peptides with disso-
ciation constants (KD) of 3 mM (Fpep), 4 mM (Wpep), 6 mM (Ypep),
and 9 mM (Lpep), respectively (Figures 3A and 3C). ClpS2 bound
Fpep most tightly (KD = 4 mM), bound Ypep (KD = 17 mM) and
Wpep (KD = 23 mM) 5 fold more weakly, and did not detectably
bind Lpep (Figures 3B and 3C). Assuming a potential detection
limit of 10% peptide bound at the highest ClpS2 concentration
tested (95 mM), we estimate that the equilibrium dissociation
constant for ClpS2-Lpep binding is greater than 800 mM. Thus,
ClpS2 binds a more restricted subset of N-degrons than does
ClpS1.
ClpS1 and ClpS2 Deliver N-End-Rule Substrates to
A. tumefaciens ClpA
Primary-sequence analysis suggested that both ClpS1 and
ClpS2 should be capable of delivering N-end-rule substrates to2–242, February 2, 2016 ª2016 Elsevier Ltd All rights reserved 233
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Figure 2. A. tumefaciens and S. elongatus
ClpS1 and ClpS2 Differ in Binding Specificity
Selected slices of a peptide blot probed with
(A) 35S-labeled ClpS1 from A. tumefaciens, (B) 35S-
labeled ClpS2 from A. tumefaciens, (C) 35S-labeled
ClpS1 from S. elongatus, and (D) 35S-labeled ClpS2
from S. elongatus. Each spot corresponds to
a single peptide with the sequence NP1-P2-
FVQELASKEV-C. The P1 residue is indicated by the
letters to the left of the blot, whereas the P2 residue
is indicated by the letters above the blot.ClpA, as each protein contains a set of conserved residues that
form the ClpA binding interface and an N-terminal extension of
sufficient length to mediate ClpA engagement and substrate de-
livery (Figures 1B, 1C, and S1A) (Guo et al., 2002; Rivera-Rivera
et al., 2014; Roma´n-Herna´ndez et al., 2011; Zeth et al., 2002). To
test this prediction directly, we purified A. tumefaciens ClpA and
assayed the ability of ClpS1 or ClpS2 to stimulate unfolding of
N-degron GFP substrates. These experiments also contained
the D87K variant of GroEL (GroELtrap) to bind unfolded GFP
and prevent its refolding, thus allowing direct monitoring of un-
folding by loss of GFP fluorescence (Weber-Ban et al., 1999).
Without ClpS, ClpA did not unfold FLFVQ-GFP (Figures 4A and
4B), but addition of ClpS1 stimulated efficient unfolding of
FLFVQ-GFP, YLFVQ-GFP, WLFVQ-GFP, and LLFVQ-GFP (Fig-
ure 4A). Likewise, ClpA efficiently unfolded FLFVQ-GFP in the
presence, but not absence, of ClpS2 (Figure 4B). However,
ClpS2 promoted slower unfolding of YLFVQ-GFP, even slower
unfolding of WLFVQ-GFP, and no detectable unfolding of
LLFVQ-GFP. We found that both ClpS1 and ClpS2 also deliver
N-degron-GFP substrates to E. coli ClpAP for degradation and
displayed similar delivery specificities to those observed in un-
folding reactions with A. tumefaciens ClpA (Figures 4C and
4D). The delivery specificities of ClpS1 and ClpS2 were largely
those expected based on our peptide-binding experiments. Dis-
crepancies could be explained if the N-degron also affects steps
subsequent to ClpS1 or ClpS2 binding in the ClpA unfolding re-
action or if the differences between the N-terminal sequences of
our peptides and GFP substrates affect binding affinity.
We next assayed the apparent binding affinities between the
ClpS adaptors and ClpA by measuring initial unfolding rates of
FLFVQ-GFP, using 100 nM ClpA6 and a range of ClpS1 or
ClpS2 concentrations (Figure 4E). With both ClpS paralogs,
half-maximal stimulation of unfolding (Kapp) occurred at ClpS1
and ClpS2 concentrations of between 400 and 500 nM, although
the maximal delivery rate was higher for ClpS1. This difference in
delivery rates might be due to the differing lengths and composi-
tions of the ClpS1 and ClpS2 N-terminal extensions. As such, we
replaced the N-terminal extension of ClpS2 with that of ClpS1
and assayed the delivery of N-degron GFP to ClpA. This mutant,
ClpS2S1NTE, displayed a hierarchy of preferred N-degrons similar234 Structure 24, 232–242, February 2, 2016 ª2016 Elsevier Ltd All rights reservedto that of wild-type ClpS2 (Figure S1B).
However, its delivery was less efficient
than either ClpS1 or wild-type ClpS2 (Fig-
ure S1C), suggesting that the ClpS1 N-ter-
minal extension, alone, cannot confer
greater delivery efficiency to ClpS2.Although ClpS1 and ClpS2 appear to bind ClpA with similar af-
finities, it is possible that one adaptor might interact more favor-
ably with ClpA during subsequent steps of the delivery reaction.
In this case, if both adaptors are present, one adaptor may
outcompete the other for delivery of substrates. Therefore, we
assayed N-degron-GFP unfolding using a mixture of ClpS1
and ClpS2. In the presence of a 1:1 mixture of ClpS1 and
ClpS2, we observed efficient unfolding of FLFVQ-GFP, reflecting
the ability of both adaptors to deliver this substrate (Figure 4F).
Moreover, ClpA unfolded YLFVQ-GFP, WLFVQ-GFP, and
LLFVQ-GFP at rates intermediate between those observed in
the ClpS1-only and ClpS2-only reactions. Thus, when both
ClpS1 andClpS2were present, neither adaptor dominated in de-
livery of substrates to ClpA. Together, our experiments suggest
that by altering the relative levels of ClpS1 and ClpS2, the
A. tumefaciens cells could tune the level of unfolding and degra-
dation of substrates with N-terminal Tyr, Trp, or Leu residues.
In addition to delivering N-end-rule substrates, E. coli ClpS
also inhibits the degradation of other substrates, including
ssrA-tagged substrates, by ClpAP. Therefore, we also tested
the ability of ClpS1 and ClpS2 to inhibit GFP-ssrA degradation
by E. coliClpAP. ClpS1 (at 2 mM)modestly inhibited the degrada-
tion of GFP-ssrA (at 1 mM) (Figure S2). ClpS2 (at 2 mM) also
weakly inhibited GFP-ssrA (at 1 mM) degradation (Figure S2).
Thus, both adaptors can inhibit GFP-ssrA degradation by
E. coli ClpAP, albeit with differing efficiencies.
Ligand-Stabilized Conformational Changes in the ClpS2
Binding Pocket
Weaddressed the structural basis of the restricted binding spec-
ificity of ClpS2 by solving crystal structures without ligand
(1.95 A˚; PDB: 4YJM), with bound Phe-amide (2.55 A˚; PDB:
4YJX), and with bound Tyr-amide (2.80 A˚; PDB: 4YKA) (Table 1;
Figures 5 and S3). Phe-amide and Tyr-amide mimic peptide-
bonded amino acids, as they have an amide in place of the
carboxyl group. Simulated annealing FO-FC omit maps strongly
support high occupancy of these substrate analogs in the bind-
ing pocket. The overall fold of each ClpS2 structure agreed well
with those ofC. crescentus and E. coli ClpS (Figures 5D and 1B).
However, soaking ligands into our apo crystals resulted in
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Figure 3. A. tumefaciens ClpS2 Is a More Selective N-End-Rule
Adaptor than ClpS1
(A)A. tumefaciensClpS1 binding to fluorescently labeled peptides with varying
N termini, as assayed by change in fluorescence anisotropy. Data are repre-
sentative of three independent experiments. Curves are non-linear least-
squares fits to a hyperbolic binding isotherm, R > 0.95.
(B)A. tumefaciensClpS2 binding to fluorescently labeled peptides with varying
N termini, as assayed by change in fluorescence anisotropy. See (A) for
experimental details. For Lpep, a linear fit was used.
(C) Summary of measured dissociation constants (KD) for A. tumefaciens
ClpS1 and ClpS2 binding to peptides with different N termini. Each KD rep-
resents an average (n = 3) ± the greater of 1 SEM or 10% of average.substantial conformational shifts (Figure 6B), with least-squares
superpositions of main-chain atoms giving a root-mean-square
deviation (RMSD) of 0.78 A˚ for the apo andPhe-bound structures
and 0.15 A˚ for the Phe- and Tyr-bound structures. The largest
backbone changes occurred in helix 2, which forms part of the
ClpS2 binding pocket (Figures 6A and 6B). A shift in helix 2
moved the His62 ND1 nitrogen about 3 A˚, allowing formation ofStructure 24, 23an important hydrogen bond with the a-amino group of the
bound ligand (Figure 6B). This movement also shifted additional
helix-2 binding-pocket residues (i.e. Met58, Ala61) to allow
accommodation and close packing against the side chain of
the bound ligand (Figures 6B and 7A). Several residues
outside of helix 2 also shifted to interact with the ligand; for
example, the side-chain carbonyl oxygen of Asn30 moved about
1 A˚ to hydrogen bond with the a-amino group of Phe-amide
(Figure 6B).
These structural results suggest that appropriate N-degron
binding stabilizes a ‘‘tight’’ binding-pocket conformation that is
energetically unfavorable and thus poorly populated in apo
ClpS2. This model, in turn, implies that there is an energetic
cost for N-degrons to bind to ClpS2, as binding must ‘‘pay’’ for
the cost of the associated conformational change. The bound
Phe side chain fits tightly into the ClpS2 pocket, with optimal hy-
drophobic and van der Waals interactions, and thus achieves a
reasonably tight binding affinity despite this energetic cost.
Modeling suggested that the smaller, but branched, Leu side
chain would clash with some atoms in the pocket observed in
the Phe-bound structure and would fill other parts of the pocket
less well than Phe (Figure 6C). As a result, the free energy of Leu
binding may not be sufficient to drive the conformational change
necessary to form the ‘‘tight’’ binding pocket (see Discussion).
In the Tyr-bound ClpS2 structure, we observed crowding near
the side-chain –OH of the tyrosine ring (Figures 7A and 7B). Spe-
cifically, the side chain of Leu28 in ClpS2, buttressed by Phe97,
clashed mildly with the Tyr -OH (3.1 A˚; Figure 7B). This clash
may explain the 4-fold weaker binding of Tyr than Phe. In
C. crescentus ClpS, by contrast, the residue corresponding to
Leu28 (Ile45) adopts a rotamer that does not clash with the
Tyr -OH group, because the residue corresponding to Phe97
(Cys114) is smaller (Figures 1C and 7B). In addition, the carbonyl
of Leu29 in ClpS2 also clashedwith the Tyr -OH (2.3 A˚; Figure 7B).
When we modeled a Trp side chain into the ClpS2 pocket, we
also observed small potential clashes with residues in the bind-
ing pocket (Figure 7C).
To test the importance of Leu28 (that appears to clash with Tyr-
amide) in determining the relative affinity of ClpS2 for different
N-degron side chains, we assayed binding to the L28A mutant.
This variant bound Ypep more strongly than the parent protein
(DDG = 0.26 kcal/mol) but bound Fpep (DDG = 0.91 kcal/mol)
and Wpep (DDG = 0.30 kcal/mol) more weakly (Figures 7D and
7E). Decreased hydrophobic packing at the base of the L28A
binding pocket presumably accounts for weaker binding to pep-
tides with N-terminal Phe and Trp residues, whereas relief of the
steric clash overcomes this effect and strengthens binding to
peptides with an N-terminal Tyr residue. Like the parent protein,
the L28A variant did not bind Lpep. Consistently, the L28AClpS2
variant supported faster ClpA unfolding of YLFVQ-GFP than
FLFVQ-GFP or WLFVQ-GFP, and did not unfold LLFVQ-GFP
(Figure 7F).
The side chain of Arg36 lines part of the ClpS2 binding pocket
(Figures 6B and 7C). The corresponding position in ClpS1 and
most ClpS orthologs isMet and has been implicated in governing
binding specificity, as a mutation to Ala in E. coli ClpS allows
binding of non-canonical b-branched Ile and Val N-degrons
(Wang et al., 2008b). We found that the R36M ClpS2
variant bound Ypep with higher affinity than the parent protein2–242, February 2, 2016 ª2016 Elsevier Ltd All rights reserved 235
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Figure 4. ClpS1 and ClpS2 Deliver N-End-
Rule Substrates to ClpA In Vitro.
(A) In vitro unfolding of N-degron GFP (1 mM) by
ClpA6 (0.5 mM) and ClpS1 (2 mM) was monitored
by loss of GFP fluorescence over time. Excess
GroELtrap (10 mM 14mer) was added to reactions to
capture unfolded GFP and prevent refolding. Data
are averages of three technical replicates and are
representative of three independent experiments.
(B) In vitro unfolding of N-degron GFP (1 mM) by
ClpA6 (0.5 mM) and ClpS2 (2 mM). The no ClpS
control is the same as in (A). See (A) for experi-
mental details.
(C) In vitro degradation of N-degron GFP (1 mM) by
E. coli ClpAP (0.4 mM ClpP14, 0.2 mM ClpA6) and
A. tumefaciens ClpS1 (2 mM) was measured by loss
of fluorescence.
(D) In vitro degradation of N-degron GFP (1 mM) by
E. coli ClpAP (0.4 mM ClpP14, 0.2 mM ClpA6) and
A. tumefaciens ClpS2 (2 mM) was measured by loss
of fluorescence. The no ClpS control is the same
as in (C).
(E) FLFVQ-GFP unfolding rates as a function of
ClpS1 and ClpS2 concentration with 100 nM ClpA6,
1 mM FLFVQ-GFP, and 5 mM GroELtrap 14mer.
Points are averages of three independent experi-
ments and errors represent ±1 SD. Curves are non-
linear least-squares fits to a hyperbolic binding
isotherm, R > 0.95. Kapp values are averages
(n = 3) ± the greater of 1 SEM or 10% of average.
(F) In vitro unfolding of N-degron GFP (1 mM) by
ClpA6 (0.5 mM), ClpS1 (1 mM), and ClpS2 (1 mM). See
(A) for experimental details.
See also Figures S1 and S2.(DDG = 0.74 kcal/mol), showed smaller improvements in bind-
ing Fpep (DDG = 0.17 kcal/mol) and Wpep (DDG = 0.30 kcal/
mol), and did not bind Lpep (Figures 7D and 7E). Consistently,
despite the R36M ClpS2 variant’s general weakness in delivery,
this adaptor displayed a large relative improvement in delivery
of YLFVQ-GFP to ClpA for unfolding, compared with the
delivery of FLFVQ-GFP (Figure 7F). In the R36M variant, elimina-
tion of charge repulsion between the Arg36 side chain and the
a-amino group of the N-degron may improve binding to all pep-
tide variants and may also allow repositioning of the Tyr side
chain to avoid steric clashes at the base of the pocket.
ClpS1 and ClpS2 Are Differentially Expressed in
A. tumefaciens
To test whether A. tumefaciens expresses the ClpS paralogs
differentially, we assayed the protein levels of ClpS1 and
ClpS2 by western blotting using cell lysates from different stages
of growth (Figure 8A). These experiments showed robust levels
of ClpS1 protein in exponential and stationary phase cells. How-
ever, substantial accumulation of ClpS2 protein was only
observed in stationary phase cells (Figures 8A and S4). Using pu-
rified ClpS1 and ClpS2 as standards, we estimated that ClpS1236 Structure 24, 232–242, February 2, 2016 ª2016 Elsevier Ltd All rights reservedprotein levels were 2.5-fold higher than
ClpS2 in mid-to-late stationary phase.
RT-qPCR measurements also detected
differential regulation of ClpS1 and ClpS2mRNA levels upon transition to stationary phase. These results
indicate that changes in ClpS1 and ClpS2 protein levels depend
upon changes in translation/degradation as well as changes in
gene expression. In combination, these experiments suggest
that the biological role of ClpS2 is largely restricted to stationary
phase.
DISCUSSION
We find thatA. tumefaciens expresses ClpS1 in both exponential
and stationary phases, whereas ClpS2 is present at substantial
levels only as cells enter the stationary phase. Moreover, our
biochemical studies show specificity differences between these
adaptor paralogs. For example, A. tumefaciensClpS1 binds pro-
teins with N-terminal Phe, Tyr, Trp, or Leu residues and delivers
them to ClpA for unfolding. These activities closely resemble
those of well-studied ClpS adaptors from bacteria that encode
only a single ClpS ortholog, a result consistent with strong
sequence homology between the ClpS and a-proteobacterial
ClpS1 families. By contrast, A. tumefaciens ClpS2 only recog-
nizes substrates with N-end Phe, Tyr, and Trp residues and fails
to bind and deliver proteins beginning with Leu. The sequences
Table 1. Crystallographic Data and Refinement Statistics
PDB ID 4YJM 4YJX 4YKA
Data Collection
Ligand None Phe-amide Tyr-amide
Space group P212121 P212121 P212121
Unit cell: a, b, c (A˚) 58.01, 92.55,
96.46
58.03, 92.99,
94.25
57.95, 92.65,
94.92
Resolution (A˚) 1.95 2.55 2.80
Wavelength (A˚) 0.979 1.54 1.54
Rsym 0.067 0.098 0.161
Rpim 0.027 0.039 0.046
No. of reflections 38,283 17,258 13,021
Completeness (%) 99.7 (100) 99.9 (100) 99.7 (96.4)
Data redundancy 7.2 (7.3) 7.1 (6.6) 12.5 (6.2)
Wilson B 31.1 36.3 44.6
hI=sðIÞi 3.21 (at
1.96 A˚)
3.43 (at
2.54 A˚)
2.12 (at
2.81 A˚)
Refinement and Validation
Rwork 0.177 0.176 0.187
Rfree 0.209 0.216 0.256
Average B factor 59.0 45 49
RMSD bonds (A˚) 0.012 0.004 0.003
RMSD angles () 1.18 0.81 0.67
Rotamer outliers (%) 0.68 0 0
Ramachandran
outliers (%)
0 0 0
Ramachandran
favored (%)
99.39 93.38 99.08
Clashscore 0.93 0.73 0.92
Clashscore percentile 100th
(n = 721)
100th
(n = 259)
100th
(n = 139)
MolProbity score 0.78 0.73 0.78
MolProbity percentile 100th
(n = 12,327)
100th
(n = 6,632)
100th
(n = 4,394)
Values in parentheses represent the highest-resolution bins: 1.98–
1.95 A˚ for PDB: 4YJM, 2.59–2.55 A˚ for PDB: 4YJX, and 2.85–
2.80 A˚ for PDB: 4YKA. Rsym =
P
hkl
P
j
Ihkl; j  hIhkli
=P
hkl
P
j
Ihkl; j and Rpim =
P
hkl
ﬃﬃﬃﬃﬃﬃ
1
n1
q Pn
j =1
Ihkl; j  hIhkli
=P
hkl
P
j
Ihkl; j ; where hIhkli is the average of
symmetry-related observations of a unique reflection. Rwork =P
jkl
jjFobsj  jFcalcjj=
P
hkl
jFobsj ; calculated over the 95% of the data in the
working set. Rfree is equivalent to Rwork except that it is calculated over
the remaining 5% of the data. Geometry was assessed using MolProbity
(Chen et al., 2009).
Figure 5. Structure of Apo and Ligand-Bound ClpS2
(A) 2FO-FC electron density map, contoured at 1.25s, for residues 66–69 in
chain A of the Apo structure.
(B) Simulated annealing FO-FC omit map, contoured at 2.0s, for the Tyr-bound
structure is shown in green. Tyr-amide (yellow), His62 (cyan), and Asp31 (cyan)
of chain A of the Tyr-bound structure are also shown.
(C) Simulated annealing FO-FC omit map, contoured at 2.0s, for the Phe-bound
structure is shown in green. Phe-amide (blue), His62 (green), and Asp31 (green)
in chain A of the Phe-bound structure are also shown.
(D) Cartoon representation, with transparent surface, of a Phe-bound ClpS2
monomer. The Phe-amide ligand (blue) is shown in stick representation.
See also Figure S3.of a-proteobacterial ClpS2 orthologs are highly conserved, and
thus this family of N-end-rule adaptors is likely to have more
stringent specificity than their ClpS1 paralogs. In combination,
these results suggest that N-end-rule proteolysis in a-proteo-
bacteria is regulated using paralogous adaptors with distinct
but overlapping specificities and expression patterns.
The affinity of A. tumefaciens ClpS1 for N-end peptides begin-
ning with Phe, Tyr, Trp, and Leu varies over a narrow (3-fold)
range. Similar narrow affinity ranges for these four canonicalStructure 24, 232–242, February 2, 2016 ª2016 Elsevier Ltd All rights reserved 237
Figure 6. The ClpS2 Binding Pocket Un-
dergoes Ligand-Stabilized Conformational
Changes
(A) Cartoon representation of Phe-boundmonomer
with helix 2 colored in cyan and its terminal resi-
dues labeled.
(B) Upper left: Ca overlay of Phe-bound (green)
and Apo (orange) structures. Upper right: Ca
overlay of monomer from Phe-bound (green) and
Tyr-bound (purple) structures. Bottom: Selected
binding-pocket residues of aligned Phe-bound
(green) and Apo (orange) structures with the bound
Phe-amide in gray. The black dotted lines repre-
sent hydrogen bonds, with the a-amino group in
the Phe-bound pocket.
(C) Left: Model of Leu in the binding pocket of the
Phe-bound structure. Yellow surfaces indicate
potential clashes with the Leu side chain. Right:
Phe-amide bound in the ClpS2 binding pocket.bacterial N-end-rule residues also occur for C. crescentus ClpS
and E. coli ClpS (Schuenemann et al., 2009; Wang et al., 2008b).
Thus, the binding pockets of these adaptors accommodate side
chains of moderately different size, shape, and polarity with
similar interaction energies. Crystal structures of free and N-de-
gron-bound C. crescentus ClpS show that the binding pocket is
very similar in the apo, Phe-bound, Tyr-bound, and Trp-bound
structures, but rearranges slightly in the Leu-bound structure
to maximize contacts with the smaller side chain (Roma´n-Her-
na´ndez et al., 2009; Wang et al., 2008b).
Strikingly, we find that the A. tumefaciens ClpS2 adaptor
shows no detectable binding to an N-terminal Leu peptide, a
novel restriction in N-degron specificity. Based on our crystal
structures, apo ClpS2 has an open peptide-binding pocket
that closes when Phe or Tyr bind. If a similar conformational
change occurs in solution, then some of the N-degron binding
energy must be used to drive this structural change. Although
this thermodynamic cost would weaken binding, it does not
explain why ClpS2 fails to bind Leu but still binds well to Phe.
Moreover, it is possible that our crystal structures do not accu-
rately represent the range of conformations present in solution.
When we model Leu in the conformation observed in the
C. crescentus ClpS structure into the closed A. tumefaciens
ClpS2 binding pocket, steric clashes occur with the side chains
of Met58 and Val39. Only one rotamer of Leu fits into the ClpS2
pocket without any of these steric clashes. However, this ro-
tamer is present in only 0.2% of leucines in the structure data-
base, whereas the rotamer observed in the Phe-amide structure
is present in 24.7% of phenylalanines in the structure database
(Chen et al., 2009). Assuming that the distribution of rotamers
in the structure database approximates the distribution of ro-
tamers in unstructured molecules in solution, we predict that
Leu binding would be120-fold weaker than Phe binding, solely
considering side-chain entropy. In addition to steric clashes,
there is a void between the modeled Leu side chain and the
Ala61 side chain (Figure 6C). In the Leu-bound C. crescentus238 Structure 24, 232–242, February 2, 2016 ª2016 Elsevier Ltd All rClpS structure, Val78 occupies the Ala61 position, and conforma-
tional shifts in the binding pocket allow the void to be filled (Ro-
ma´n-Herna´ndez et al., 2009). In addition, in A. tumefaciens
ClpS2, the side chain of Leu28 packs closely against bound
Phe, but would provide only weak van der Waals interactions
with bound Leu. In the C. crescentus ClpS structure, the corre-
sponding Ile45 adopts a rotamer that packs less tightly against
bound Phe, leading to a smaller energy difference between
Leu and Phe interactions at the base of the binding pocket. We
propose that Leu binding to ClpS2 is reduced to an undetectable
level because the binding pocket cannot rearrange to avoid
clashes and minimize the impact of lost van der Waals and hy-
drophobic interactions. Support for this model comes from
studies of protein stability, where the Phe7 to Leu mutation in
barnase does not result in structural adaptation and destabilizes
the native structure by 4.6 kcal/mol (Chen et al., 1995; Kellis
et al., 1988). An energetic change of comparable magnitude
would weaken ClpS2 affinity for Leu more than 2,000-fold
compared with Phe. Thus, ClpS2 likely optimizes Phe binding,
maintaining an affinity comparable with that of ClpS1, at the
expense of Leu binding by employing conformational changes
and remodeling of the substrate-binding pocket.
How might increased ClpS2 levels, as cells enter stationary
phase, affect N-end-rule degradation? If ClpS1 is in excess of
ClpA in the cell, then increasing the levels of ClpS2 should
decrease the rate of degradation of proteins with N-terminal
Tyr, Trp, and Leu, increasing their steady-state levels in the
cell. Irrespective of ClpA levels, however, increased ClpS2would
focus degradation on substrates with N-terminal Phe (Figure 8B).
Recent studies suggest that Leu is the most abundant E. coli
N-degron, followed by Phe (Humbard et al., 2013; Ninnis et al.,
2009; Schmidt et al., 2009). If these observations hold true for
A. tumefaciens, elevated levels of ClpS2 could affect the prote-
ome by favoring degradation of Phe substrates over Leu sub-
strates. Moreover, specific substrates with N-terminal Phe may
need to be degraded more efficiently during stationary phaseights reserved
AB C
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Figure 7. ClpS2 Disfavors Binding of Tyr and Trp via Steric Clashes
(A) Surface representation cross sections of the ClpS2 binding pocket in the Apo, Phe-bound, and Tyr-bound structures. Arrows indicate rotations and shifts in
residues in the Apo pocket required to form the Phe- and Tyr-bound pockets.
(B) Left: Dot representation (representing the van der Waals surface of atoms) of bound Tyr-amide and selected residues at the base of the ClpS2 binding pocket
in the Tyr-bound structure. Right: Dot representation of bound Tyr peptide and selected residues at the base of the C. crescentus ClpS binding pocket
(PDB: 3DNJ).
(C) Roles of the ClpS2 residues that select against Tyr or Trp binding in the ClpS2 binding pocket. Only Tyr-amide is shown bound in the ClpS2 pocket.
(D) Summary of measured dissociation constants (KD) for ClpS2 mutants and each peptide from Figure 3. Each KD represents an average (n = 3) ± the greater of
1 SEM or 10% of average.
(E) Summary of the calculated DDG values for each mutant binding to Fpep, Ypep, andWpep. Each value represents an average (n = 3) ± the greater of 1 SEM or
10% of average.
(F) Initial rates of N-degron GFP unfolding (% N-degron GFP unfolded/s) for wild-type (WT), L28A, and R36M ClpS2. Conditions are the same as described in
Figure 4A. Rates represent an average (n = 3) ± the greater of 1 SEM or 10% of average.than during exponential phase. Conversely, proteins with N-ter-
minal Tyr, Trp, and/or Leu might be advantageous at higher
levels during stationary phase. As other clades of proteobacteria
do not employ a ClpS2 adaptor, such substrates would likely
serve a-proteobacterial-specific functions. Identifying these
substrates could provide insights into the biological role of the
bacterial N-end rule and why many a-proteobacteria have
evolved a tunable recognition system.
Interestingly, a-proteobacteria are not alone in employing
N-end-rule adaptors with differing specificities. We found thatStructure 24, 23S. elongatusClpS1 bound N-terminal Phe, Tyr, and Trp, whereas
ClpS2 bound N-terminal Leu, Phe, Tyr, Val, and Ile. The ability of
S. elongatus ClpS2 to recognize Val and Ile may be a conse-
quence of the presence of Phe74 at the ‘‘gating’’ methionine po-
sition, which is responsible for excluding b-branched amino
acids from the E. coli ClpS binding pocket (Wang et al.,
2008b). Indeed, Tyr and Phe are often observed at this position
in the ClpS-like domains of N-end-rule-specific E3 ligases that
recognize N-terminal Ile (Lupas and Koretke, 2003; Varshavsky,
2011). The ability of ClpS2 to bind substrates with N-terminal Val2–242, February 2, 2016 ª2016 Elsevier Ltd All rights reserved 239
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Figure 8. ClpS1 and ClpS2 Are Differentially Expressed in
A. tumefaciens
(A) Representative western blot of cell lysate samples from different stages of
growth. Top: Growth curve of A. tumefaciens GV3101 that corresponds to the
western blots shown below. Bottom: Selected slices of western blots using
anti-ClpS1 or anti-ClpS2 polyclonal antibodies. Ponceau staining of total
protein is shown as a loading control. A western blot of purified ClpS1 and
ClpS2 is shown to the right to demonstrate antibody specificity.
(B) A model illustrating the potential downstream effect of altered ClpS1 and
ClpS2 levels on the bacterial proteome. As levels of ClpS2 increase relative to
ClpS1, substrates with N-terminal Phe (gray) may be degraded more rapidly,
leading to lower steady-state levels of these proteins. In contrast, substrates
withN-terminal Tyr (red), N-terminal Trp (purple), andN-terminal Leu (blue)may
be degraded less often, leading to higher steady-state levels of these proteins.
See also Figure S4.is intriguing, as methionine aminopeptidase is predicted to
cleave many of the N-terminal Met residues adjacent to Val.
Thus, in their native states, many proteins in S. elongatus (111
of the 2,657 proteins in the proteome) may present N-degrons
that can be recognized by ClpS2.240 Structure 24, 232–242, February 2, 2016 ª2016 Elsevier Ltd All rOur work supports the idea that both cyanobacteria and
a-proteobacteria can tune N-end-rule recognition via expression
of different ClpS proteins. This strategy represents an interesting
parallel with the eukaryotic N-end rule. For example, mammals
employ at least five N-end-rule-specific E3 ligases that recog-
nize different classes of N-terminal residues and facilitate their
polyubiquitination (Varshavsky, 2011). By tuning the levels of
these enzymes, cells can modulate which substrates will be
recognized and which will avoid degradation. Similarly, bacteria
with multiple ClpS proteins can regulate which N-end-rule sub-
strate classes are most efficiently recognized for degradation.
In combination with previous studies, our work demonstrates
that evolution can alter the binding pocket of ClpS to either
expand or narrow N-degron binding specificity. These features
may make ClpS an attractive module for engineering artificial
protein-interaction networks.
EXPERIMENTAL PROCEDURES
Strains and Plasmids
All proteins were expressed in E. coli strain BL21 (DE3) transformed with
appropriate plasmid vectors. A. tumefaciens ClpS1, ClpS2, and ClpA ORFs
were amplified from A. tumefaciens GV3101 (a gift from Mary Gehring, White-
head Institute/MIT and Graham Walker, MIT) by colony PCR. S. elongatus
ClpS1 and ClpS2 were amplified from S. elongatus strain PCC 7942 genomic
DNA (ATCC) using standard molecular biology techniques. The ClpS1 and
ClpS2 ORFs were inserted into a pET23b vector at the C terminus of
H6-SUMO. ClpA was inserted into pET23b with a C-terminal H6 tag. For
35S-labeled proteins, E. coli Bl21 cultures expressing the desired protein
were grown at 37C in LB broth to OD600 = 1, centrifuged, resuspended in
M9medium + 10%LBbroth, supplementedwith EXPRESS [35S]-protein label-
ing mix (PerkinElmer), and grown for 4 hr. Western blotting experiments were
performed using A. tumefaciens strain GV3101.
Peptides and Proteins
Peptide blots were synthesized by standard Fmoc techniques using a
ResPep SL peptide-blot synthesizer (Intavis). Peptides used for binding
studies (FRFVQELASKEVC, YRFVQELASKEVC, LRFVQELASKEVC, and
WRFVQELASKEVC) were synthesized by standard Fmoc techniques using a
solid-phase peptide synthesizer (Apex 396), labeled with fluorescein-5-malei-
mide (Life Technologies), and purified by high-performance liquid chromatog-
raphy (Wang et al., 2008a). L-Phe-amide and L-Tyr-amide were purchased
from Sigma-Aldrich.
ClpS1, ClpS2, and GFP variants (FLFVQ-GFP, YLFVQ-GFP, and LLFVQ-
GFP) were expressed as H6-SUMO-fusion proteins, subjected to Ni-nitrilotri-
acetic acid (NTA) affinity chromatography before and after cleavage with
Ulp1 protease, and purified by gel filtration and ion-exchange chromatography
as described by Roma´n-Herna´ndez et al. (2011). 35S-Labeled proteins were
purified similarly, except that the size-exclusion step was omitted. ClpA was
purified by Ni-NTA chromatography (Qiagen), followed by gel filtration on
Sephacryl-300 16/60 (GE Healthcare). The protein was concentrated and
stored in reaction solution (50 mM HEPES [pH 7.5], 300 mM NaCl, 20 mM
MgCl2, 0.5 mM DTT, 10% glycerol). GroEL D87K was purified by 30% and
60%AmSO4 precipitations, incubated with Affi-gel Blue gel (Bio-Rad), purified
by ion-exchange chromatography on Mono Q 5/50 Gl (GE Healthcare), and
stored in solution A (50mM Tris [pH 7.5], 50 mMKCl, 1 mMDTT, 10% glycerol)
as described by Burton et al. (2001).
Peptide Blots
Peptide blots were blocked sequentially with 13 PBS plus 0.5% Tween 20
without and with 10 mg/ml BSA. The blots were then incubated with 625 nM
35S-labeled proteins in ClpS solution (20 mM HEPES [pH 7.5], 150 mM KCl,
10% glycerol, 1 mM DTT), exposed to a phosphor screen for 24–60 hr (Molec-
ular Dynamics), and imaged using Typhoon FLA 9500 laser scanner (GE
Healthcare).ights reserved
Crystallography
Crystals of A. tumefaciens ClpS2 were grown at 18C for 2 weeks in hanging
drops containing 1 ml of protein solution (3.5–5 mg/ml) and 1 ml of reservoir so-
lution (2.2 M AmSO4, 0.2 M sodium formate). Crystals were briefly dipped in
reservoir solution plus 20% ethylene glycol for cryoprotection and were
flash-frozen. Data were collected at the NE-CAT 24-ID-E beamline (Argonne
National Laboratory). For ligand-bound crystals, apo crystals were soaked in
reservoir solution with 2 mM L-Phe-amine or L-Tyr-amide for 5 min and then
were cryoprotected and flash-frozen. Data were collected using a Rigaku Mi-
cromax 007-HF rotating anode equipped with Varimax-HF mirrors, a Saturn
944 detector, and an Oxford Cryosystems 700 series cold head. Diffraction
data were indexed, integrated, and scaled using HKL2000. Initial phases for
the apo structure (PDB: 4YJM) were determined bymolecular replacement us-
ing the PHASER module (McCoy et al., 2007) in PHENIX with a C. crescentus
ClpS structure (PDB: 3DNJ) as a search model. Subsequent structures (PDB:
4YJX, 4YKA) were solved using the apo structure as a startingmodel for refine-
ment. Final structures were obtained using iterative model building in Coot
(Emsley et al., 2010) and refinement in PHENIX (Adams et al., 2010). To
generate simulated annealing FO-FC omit maps, we deleted ligands from the
final structures and ran simulated annealing in PHENIX.
Solution Binding
Binding of peptides to ClpS1 or ClpS2 at 30Cwas monitored by fluorescence
anisotropy (495 nm excitation; 515 nm emission) using a Photon Technology
International fluorimeter. Fluorescent peptide (200 nM) and different concen-
trations of ClpS1 or ClpS2 protein in ClpS solution were incubated until equi-
librium was reached. Data were fitted to a hyperbolic binding isotherm using a
non-linear least-squares algorithm. Raw anisotropy values were normalized
using the equation ðX  BÞ=A, where X is the raw anisotropy, B is the value of
the fit in the absence of ClpS (0.02–0.05), and A is the amplitude of the fit
(0.07–0.12). KD values are averages (n = 3) ± the greater of 1 SEM or 10% of
the average. For mutant analysis, DDG values were calculated as
DGmut  DGWT =RT ln

KD mut=KD WT

; where R = 0.00198 kcal K1 mol1
and T is the temperature in Kelvin.
Unfolding and Degradation Assays
For unfolding reactions, ClpA6 (0.5 mM), ClpS1 or ClpS2 (2 mM), N-degron GFP
(1 mM), and GroEL14 D87K (10 mM) were pre-incubated for 3 min in reaction so-
lution at 30C. For the mixed ClpS experiments, 1 mM ClpS1 and 1 mM ClpS2
were used. Reactions were initiated by addition of ATP and a regeneration sys-
tem (16 mM ATP, 200 mg/ml creatine kinase, 20 mM creatine phosphate). GFP
unfolding was monitored by loss of fluorescence (420 nm excitation; 540 nm
emission), and data were normalized to the fluorescence at time zero. For
further analysis, average initial rates of unfolding (in % N-degron GFP/s,
n = 3) were calculated. Errors for initial rates of unfolding are ± the greater of
1 SEM or 10% of the average.
Experiments to monitor the effect of different concentrations of ClpS on
N-degron GFP (1 mM) unfolding contained ClpA6 (0.1 mM), GroEL14 D87K
(5 mM), and ATP and the regeneration system. Initial rates were converted to
units of GFP concentration using a standard curve and normalized to the total
ClpA6 concentration.Kapp values are averages (n = 3) ± the greater of 1 SEM or
10% of the average.
Degradation reactions were performed with E. coli ClpA6 (0.2 mM), E. coli
ClpP14 (0.4 mM), ClpS1 or ClpS2 (2 mM), and N-degron GFP (1 mM). Reactions
and data analysis were carried out in the same manner as for the unfolding
assays.
Western Blotting
A. tumefaciens strain GV3101 was grown at 28C in LB broth with 50 mg/ml
gentamycin and 10 mg/ml rifampicin. Cells were removed at different times
during growth, lysed in Laemmli sample buffer, and electrophoresed on
Mini-PROTEAN TGX 4%–15% (w/v) pre-cast gels (Bio-Rad). Proteins were
transferred to Immobilon-Pmembranes (EMDMillipore) in a wet transfer appa-
ratus (Bio-Rad). Membranes were probed with polyclonal antibodies (pro-
duced by Covance Research Products) raised against ClpS1 (1:50 dilution)
or ClpS2 (1:25 dilution) overnight at 4C, incubated with goat anti-rabbit immu-
noglobulin G-alkaline phosphatase conjugate (Bio-Rad; 1:10,000 dilution) forStructure 24, 231 hr at room temperature, and developed with alkaline phosphatase dephos-
phorylates ECF Substrate (GE Healthcare). The blots were exposed with a
blue laser using a Typhoon FLA 9500 scanner (GE Healthcare). For estimation
of relative amounts of ClpS1 and ClpS2, bands were quantified using
ImageQuant (GE Healthcare) and compared with standard curves of purified
proteins within the same blot.
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